FDA Inspection 1046583 — Biogen, Inc.
The FDA completed an inspection of Biogen, Inc. on Feb 13, 2018 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 13, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cambridge, MA (United States)